Completed OBSERVATIONAL NCT04058665

Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery

Sponsor: Baxter Healthcare Corporation

Interventions Floseal

Updated 8 times since 2019 Last updated: Apr 13, 2023 Started: Jun 18, 2019 Primary completion: Mar 1, 2022 Completion: Mar 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Blood Loss, this trial is completed. The trial is conducted by Baxter Healthcare Corporation and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2023 — Jul 2024 [monthly]

Completed
May 2022 — May 2023 [monthly]

Completed

Status: Active Not Recruiting → Completed
Oct 2021 — May 2022 [monthly]

Active Not Recruiting

▶ Show 3 earlier versions

Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting
Oct 2020 — Jan 2021 [monthly]

Active Not Recruiting
Sep 2019 — Oct 2020 [monthly]

Active Not Recruiting

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter Healthcare Corporation
Johns Hopkins University

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States